Tandem Diabetes Care Stock News

CGM device stocks Medtronic (MDT), Dexcom (DXCM) and Tandem Diabetes (TNDM) are expected to continue their run over the next few months.

Data presented at the ATTD conference demonstrates Tandem Diabetes Care's (TNDM) Control-IQ technology's ability to make a positive and sustained impact on diabetes care.

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care announced positive real-world data from Control-IQ advanced hybrid closed-loop technology at international diabetes conference.

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

Investors continue to be optimistic about Tandem Diabetes (TNDM) on strong quarterly results and robust pump sales.

Tandem Diabetes (TNDM) is witnessing high international demand for the t:slim X2 pump.

Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q1 2021 Results - Earnings Call Transcript

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of 53.33% and 14.98%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the st

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2021 results after the f

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and shipments.

Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.

Both of these companies have a long runway for growth.

Tandem Diabetes (TNDM) is expects t:sport to be a major growth catalyst for 2022.

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care today announced the appointment of Jordan Pinsker, MD, to Vice President and Medical Director, effective April 26, 2021.